Evoke Pharma’s Abstract Entitled “Superiority of Nasal Spray Compared to Orally Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients” to Be Presented at The American College of Gastroenterology (ACG) 2023 Annual Meeting
October 18, 2023 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
Viral Gastroenteritis Global Market Report 2023: A $7.68 Billion Market by 2027 - Product Innovation and FDA Approvals Fuel Growth to 2032
October 10, 2023 07:18 ET
|
Research and Markets
Dublin, Oct. 10, 2023 (GLOBE NEWSWIRE) -- The "Viral Gastroenteritis Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global viral gastroenteritis market is...
US Digestive Health and UnitedHealthcare Reach In-Network Coverage Agreement
September 28, 2023 10:00 ET
|
US Digestive Health
US Digestive Health (USDH) and UnitedHealthcare® Insurance and their affiliate health plans have agreed to a new contract for USDH providers.
US Digestive Health Announces Partnership with GI Specialists of Delaware
September 14, 2023 10:00 ET
|
US Digestive Health
EXTON, Pa., Sept. 14, 2023 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the largest gastroenterology (GI) practices in the United States, today announced its partnership with GI...
US Digestive Health Welcomes Nine New Providers
August 24, 2023 10:00 ET
|
US Digestive Health
EXTON, Pa., Aug. 24, 2023 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the largest gastroenterology (GI) practices in the United States, today announced the addition of nine physicians...
US Digestive Health Announces Practice Expansion in Bucks County
August 17, 2023 10:00 ET
|
US Digestive Health
EXTON, Pa., Aug. 17, 2023 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the largest gastroenterology practices in the United States, today announced the opening of its new office location...
An Old Dog with a New Trick… Ellodi’s APT-1011 Promises EoE Patients a Convenient and Potent Treatment Alternative
August 15, 2023 15:40 ET
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Since launching in May 2022, Sanofi/Regeneron’s Dupixent has been well received by gastroenterologists and allergists as an advancement for...
US Digestive Health Expands Access to Advanced Gastroenterology Care through its Partnership with Blair Gastroenterology Associates
August 08, 2023 10:00 ET
|
US Digestive Health
EXTON, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the largest gastroenterology practices in the United States, managed by US Digestive Health Management (USDHM), a...
The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome’s role in health and diseases
July 31, 2023 16:20 ET
|
Biocodex Canada
The Biocodex Microbiota Foundation is looking for academics and scientists in Canada to apply for a €25,000 research grant aimed at helping advance the study of the gut microbiome MONTREAL, July 31,...
Evoke Pharma and EVERSANA Announce Abstract Selection for Plenary Oral Presentation at The American College of Gastroenterology (ACG) 2023 Annual Meeting
July 25, 2023 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., and CHICAGO, July 25, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI)...